Pharma Pricing
74 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Adri van den Berg
Scoop.it!

Insurers Scrutinize Drug Costs After $84000 Sovaldi Surprise - International Business Times

Insurers Scrutinize Drug Costs After $84000 Sovaldi Surprise - International Business Times | Pharma Pricing | Scoop.it
International Business Times Insurers Scrutinize Drug Costs After $84000 Sovaldi Surprise International Business Times When comparable competitors, or a generic version is on the market about a decade later, insurers have room to steer patients...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Prices of generic drugs soar as mergers reduce competition - Florida Times-Union

Prices of generic drugs soar as mergers reduce competition - Florida Times-Union | Pharma Pricing | Scoop.it
Florida Times-Union
Prices of generic drugs soar as mergers reduce competition
Florida Times-Union
Hardly a week goes by without news of another acquisition in the pharmaceutical industry.
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

A 4-week hep C cure? Bristol to test drugs with Gilead's Sovaldi - WKZO

A 4-week hep C cure? Bristol to test drugs with Gilead's Sovaldi - WKZO | Pharma Pricing | Scoop.it
A 4-week hep C cure? Bristol to test drugs with Gilead's Sovaldi WKZO Pharma is looking at it as cost per cure," said John Whang, co-president of Reimbursement Intelligence, which works with pharmaceutical companies and payers to help determine...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Is there a just price for pharmaceuticals?

Is there a just price for pharmaceuticals? | Pharma Pricing | Scoop.it
In America’s ongoing efforts to address the rate of health care spending, there has been a renewed focus on the prices paid for pharmaceuticals.  The poster child is Gilead’s Sovaldi, a once-a-day ...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Teva Announces First Approval and Launch of Generic Lovaza® Capsules in the ... - MarketWatch

Teva Announces First Approval and Launch of Generic Lovaza® Capsules in the ... - MarketWatch | Pharma Pricing | Scoop.it
Teva Announces First Approval and Launch of Generic Lovaza® Capsules in the ...
MarketWatch
...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

MassBio panel tackles drug industry's bad reputation - Boston Business Journal (blog)

MassBio panel tackles drug industry's bad reputation - Boston Business Journal (blog) | Pharma Pricing | Scoop.it
MassBio panel tackles drug industry's bad reputation Boston Business Journal (blog) And while the companies represented on the panel were not the same Big Pharma companies responsible for the negative public perception of the industry, the issues...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Macroeconomic developments currently looming over Turkey's pharmaceutical ... - PR Web (press release)

Macroeconomic developments currently looming over Turkey's pharmaceutical ... - PR Web (press release) | Pharma Pricing | Scoop.it
Macroeconomic developments currently looming over Turkey's pharmaceutical ...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

DoP sets up inter-ministerial panel to fix prices of patented drugs

DoP sets up inter-ministerial panel to fix prices of patented drugs | Pharma Pricing | Scoop.it
An inter-ministerial committee of joint secretaries of different ministries has been formed by the Department of Pharmaceuticals (DoP) to look into the issues and suggest ways and means to fix the prices of patented drugs in ...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Surprising Claims About Orphan Drugs? - Motley Fool

Surprising Claims About Orphan Drugs? Motley Fool Although the regulatory and marketing benefits for orphan drugs have undoubtedly spurred innovation for diseases that otherwise would go unnoticed due to profitability issues, the eye-popping price...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Merck Serono supports India’s two-tier drug pricing policy - The Economic Times

Merck Serono supports India’s two-tier drug pricing policy - The Economic Times | Pharma Pricing | Scoop.it
Merck Serono, has not only become the latest global giant to support lower pricing for emerging markets but has also opposed incremental innovation.
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

J.P. Morgan: Pharma's Agenda for 2014 - PharmExec.com (blog)

J.P. Morgan: Pharma's Agenda for 2014
PharmExec.com (blog)
Presenters at the 32nd annual J.P.
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

GW Pharmaceuticals Announces Agreement on Sativex Pricing in ...

GW Pharmaceuticals Announces Agreement on Sativex Pricing in ... | Pharma Pricing | Scoop.it
London, UK 23 September 2013 GW Pharmaceuticals plc (AIM GWP, Nasdaq GWPH, GW ) announced today that agreement for a revised mutually-acceptable reimbursement p.
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

UAE Slashes Prices of 205 Drugs - Gulf Business News

UAE Slashes Prices of 205 Drugs - Gulf Business News | Pharma Pricing | Scoop.it
UAE Slashes Prices of 205 Drugs
Gulf Business News
The UAE's health ministry has announced the price reduction of 205 drugs, including 14 used for the treatment of diabetes, state news agency WAM reported.
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Navigating The New World Of Value-Based Healthcare

Navigating The New World Of Value-Based Healthcare | Pharma Pricing | Scoop.it
This applies particularly to high-priced drugs for cancer and rare diseases. These trends are driving a need for value-based pricing. In the U.S., the Patient Protection and Affordable Care Act (PPACA) of 2010 has far-reaching ...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Launch price of drugs to be capped - Business Standard (blog)

Launch price of drugs to be capped Business Standard (blog) “The monitoring division will monitor the prices of these single ingredient formulations launched by manufacturers for the first time on the basis of monthly MRP (maximum retail...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Bitter Pill To Swallow: Can The US Market Bear The Cost Of Sovaldi? - Forbes

Bitter Pill To Swallow: Can The US Market Bear The Cost Of Sovaldi? - Forbes | Pharma Pricing | Scoop.it
Forbes
Bitter Pill To Swallow: Can The US Market Bear The Cost Of Sovaldi?
Forbes
... for this devastating disease.
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

WHO calls for access to drugs for hepatitis C

WHO calls for access to drugs for hepatitis C | Pharma Pricing | Scoop.it
New guidance on the diagnosis and treatment of hepatitis C worldwide strengthens the arm of campaigners who want pharmaceutical companies to slash the prices of new drugs that can cure most cases (Pricing for new anti - #hepC drugs is now a global...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Hit $1000-a-day drug has insurers panicking - MSN Money

Hit $1000-a-day drug has insurers panicking - MSN Money | Pharma Pricing | Scoop.it
Hit $1000-a-day drug has insurers panicking MSN Money Pharmacy-benefits manager Express Scripts (ESRX) is checking with doctors on whether some patients could wait for treatment until rival drugs reach the market and help to push the price down --...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Ireland and the impact of reference pricing - PMLiVE

Ireland and the impact of reference pricing - PMLiVE | Pharma Pricing | Scoop.it
Ireland and the impact of reference pricing PMLiVE Industry body the IPHA (Irish Pharmaceutical Healthcare Association) has not commented on the reference pricing system since its implementation, but it had expressed doubts regarding the “security...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

BioMarin Prices New Drug For Ultra-Rare Disease at $380K Per Year

BioMarin Prices New Drug For Ultra-Rare Disease at $380K Per Year | Pharma Pricing | Scoop.it
Adam Feuerstein's biotechnology blog, Biotech Beat, features Adam's opinion and analysis on an array of biotech and pharmaceutical stocks and companies.
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Healthcare restructuring pressures drug developers ... - EBD Group

They must provide more coverage despite greater pricing constraints, Bernstein said. “Payers are responding by demanding evidence that drugs work, and are limiting the use of the most expensive drugs.
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Huge Pressures on Pricing in Medical Devices & Pharmaceuticals

Snippet of David E.I. Pyott, CEO of Allergan, speaking at OIS @ AAO 2013. The title of the talk is "Sustaining Innovation in Ophthalmology - A View from the ...
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

PHARMAC tender reveals vibrant market for pharmaceuticals

PHARMAC tender reveals vibrant market for pharmaceuticals | Pharma Pricing | Scoop.it
PHARMAC runs a tender each year, asking pharmaceutical suppliers to provide pricing proposals for off-patent medicines listed on the Pharmaceutical …PHARMAC tender reveals vibrant market for pharmaceuticals.
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Intercept Pharmaceuticals Inc: A Whole New Class of Blockbuster Drug Is Born - Motley Fool

Intercept Pharmaceuticals Inc: A Whole New Class of Blockbuster Drug Is Born
Motley Fool
The most interesting thing to watch is how Intercept prices OCA if it's approved.
more...
No comment yet.
Scooped by Adri van den Berg
Scoop.it!

Department of Pharmaceuticals replaces Committee for Patented ...

Department of Pharmaceuticals replaces Committee for Patented ... | Pharma Pricing | Scoop.it
The committee had originally come into being through a memorandum in February, 2007, comprising seven members including the Chairman and representatives from the DoP, the National Pharmaceutical Pricing Authority, ...
more...
No comment yet.